Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-03 Sale | 2025-03-05 4:35 pm | Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer | 4,595 | $3.152 | $14,483 | 3,196,648 (Direct) | View |
| 2025-03-03 Sale | 2025-03-05 4:32 pm | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 4,595 | $3.1663 | $14,549 | 3,196,652 (Direct) | View |
| 2025-03-03 Sale | 2025-03-05 4:32 pm | Amylyx Pharmaceuticals Inc. | AMLX | Mazzariello Gina Chief Legal Officer | 1,611 | $3.1175 | $5,022 | 133,310 (Direct) | View |
| 2025-02-24 Sale | 2025-02-26 4:35 pm | Amylyx Pharmaceuticals Inc. | AMLX | Mazzariello Gina Chief Legal Officer | 4,169 | $3.153 | $13,145 | 134,921 (Direct) | View |
| 2025-02-03 Sale | 2025-02-05 4:58 pm | Amylyx Pharmaceuticals Inc. | AMLX | Mazzariello Gina Chief Legal Officer | 3,678 | $3.4908 | $12,839 | 139,090 (Direct) | View |
| 2025-02-03 Sale | 2025-02-05 4:55 pm | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 11,851 | $3.4687 | $41,108 | 3,201,247 (Direct) | View |
| 2025-02-03 Sale | 2025-02-05 4:54 pm | Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer | 11,855 | $3.4672 | $41,104 | 3,164,933 (Direct) | View |
| 2025-01-06 Sale | 2025-01-08 5:29 pm | Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer | 7,471 | $4.0425 | $30,202 | 3,176,788 (Direct) | View |
| 2025-01-06 Sale | 2025-01-08 5:26 pm | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 7,471 | $4.0466 | $30,232 | 3,213,098 (Direct) | View |
| 2024-12-02 Sale | 2024-12-03 5:21 pm | Amylyx Pharmaceuticals Inc. | AMLX | Bedrosian Camille L Chief Medical Officer | 5,421 | $5.5354 | $30,007 | 138,380 (Direct) | View |
| 2024-09-30 Sale | 2024-10-02 6:53 pm | Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer | 18,589 | $3.197 | $59,429 | 3,120,569 (Direct) | View |
| 2024-09-30 Sale | 2024-10-02 6:53 pm | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 18,589 | $3.1962 | $59,414 | 3,220,569 (Direct) | View |
| 2024-09-30 Sale | 2024-10-02 6:50 pm | Amylyx Pharmaceuticals Inc. | AMLX | Bedrosian Camille L Chief Medical Officer | 11,442 | $3.1952 | $36,559 | 143,801 (Direct) | View |
| 2024-09-30 Sale | 2024-10-02 6:48 pm | Amylyx Pharmaceuticals Inc. | AMLX | Mazzariello Gina Chief Legal Officer | 8,709 | $3.1967 | $27,840 | 142,768 (Direct) | View |
| 2024-09-12 Purchase | 2024-09-16 5:30 pm | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 40,000 | $2.5342 | $101,368 | 259,995 (Indirect Direct) | View |
| 2024-09-05 Purchase | 2024-09-09 4:05 pm | Amylyx Pharmaceuticals Inc. | AMLX | Firestone Karen Director | 50,000 | $2.1318 | $106,590 | 55,000 (Direct) | View |
| 2024-09-03 Purchase | 2024-09-05 7:26 pm | Amylyx Pharmaceuticals Inc. | AMLX | MILNE GEORGE M JR Director | 100,000 | $2.198 | $219,800 | 858,571 (Direct) | View |
| 2024-05-14 Purchase | 2024-05-16 7:37 pm | Amylyx Pharmaceuticals Inc. | AMLX | Quimi Daphne Director | 5,000 | $1.8872 | $9,436 | 5,000 (Direct) | View |
| 2024-05-15 Sale | 2024-05-16 7:36 pm | Amylyx Pharmaceuticals Inc. | AMLX | Mazzariello Gina Chief Legal Officer | 10,455 | $1.8799 | $19,654 | 151,477 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-06 Option Award | 2025-03-10 8:34 pm | N/A 2035-03-05 | Amylyx Pharmaceuticals Inc. | AMLX | Mazzariello Gina Chief Legal Officer | 159,628 | $0 | 292,938 (Direct) | View |
| 2025-03-06 Option Award | 2025-03-10 8:32 pm | N/A 2035-03-05 | Amylyx Pharmaceuticals Inc. | AMLX | Bedrosian Camille L Chief Medical Officer | 171,050 | $0 | 309,430 (Direct) | View |
| 2025-03-06 Option Award | 2025-03-10 8:30 pm | N/A 2035-03-05 | Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer | 450,295 | $0 | 3,646,943 (Direct) | View |
| 2025-03-06 Option Award | 2025-03-10 8:28 pm | N/A 2035-03-05 | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 450,295 | $0 | 3,646,947 (Direct) | View |
| 2025-03-06 Option Award | 2025-03-10 8:28 pm | N/A 2035-03-05 | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 171,050 | $0 | 431,045 (Direct) | View |
| 2025-02-05 Exercise | 2025-02-06 8:17 pm | N/A 2025-02-26 | Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer | 36,310 | $0 | 3,201,243 (Direct) | View |
| 2025-02-05 Exercise | 2025-02-06 8:17 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer | 36,310 | $1.57 | 3,201,243 (Direct) | View |
| 2025-01-24 Gift | 2025-01-28 4:55 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | MILNE GEORGE M JR Director | 27,910 | $0 | 830,661 (Direct) | View |
| 2024-11-04 Exercise | 2024-11-06 7:24 pm | N/A 2025-02-26 | Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer | 63,690 | $0 | 3,220,569 (Direct) | View |
| 2024-11-04 Exercise | 2024-11-06 7:24 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer | 63,690 | $1.57 | 3,220,569 (Direct) | View |
| 2024-09-23 Exercise | 2024-09-25 5:56 pm | N/A 2025-02-26 | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 1,857 | $0 | 3,239,158 (Direct) | View |
| 2024-09-23 Exercise | 2024-09-25 5:56 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 1,857 | $1.57 | 3,239,158 (Direct) | View |
| 2024-09-12 Exercise | 2024-09-16 5:39 pm | N/A 2025-02-26 | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 34,449 | $0 | 3,239,158 (Direct) | View |
| 2024-09-12 Exercise | 2024-09-16 5:39 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 34,449 | $1.57 | 3,239,158 (Direct) | View |
| 2023-08-23 Exercise(A) | 2024-09-05 7:55 pm | N/A 2031-01-25 | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 18,165 | $0 | 457,158 (Direct) | View |
| 2023-08-23 Exercise(A) | 2024-09-05 7:55 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 18,165 | $6.88 | 457,158 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-07 4:52 pm | N/A 2034-06-05 | Amylyx Pharmaceuticals Inc. | AMLX | FONTEYNE PAUL R. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-07 4:50 pm | N/A 2034-06-05 | Amylyx Pharmaceuticals Inc. | AMLX | Firestone Karen Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-07 4:49 pm | N/A 2034-06-05 | Amylyx Pharmaceuticals Inc. | AMLX | Zeiher Bernhardt G Director | 5,753 | $0 | 5,753 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-07 4:44 pm | N/A 2034-06-05 | Amylyx Pharmaceuticals Inc. | AMLX | MILNE GEORGE M JR Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-07 4:42 pm | N/A 2034-06-05 | Amylyx Pharmaceuticals Inc. | AMLX | Quimi Daphne Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-04-16 Option Award | 2024-04-18 8:23 pm | N/A 2034-04-15 | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 211,180 | $0 | 372,495 (Direct) | View |
| 2024-04-16 Option Award | 2024-04-18 8:21 pm | N/A 2034-04-15 | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 559,850 | $0 | 3,582,852 (Direct) | View |
| 2024-04-16 Option Award | 2024-04-18 8:20 pm | N/A 2034-04-15 | Amylyx Pharmaceuticals Inc. | AMLX | Mazzariello Gina Chief Legal Officer | 190,560 | $0 | 271,932 (Direct) | View |
| 2024-04-16 Option Award | 2024-04-18 8:20 pm | N/A 2034-04-15 | Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer | 559,850 | $0 | 3,519,158 (Direct) | View |
| 2024-04-16 Option Award | 2024-04-18 8:19 pm | N/A 2034-04-15 | Amylyx Pharmaceuticals Inc. | AMLX | Bedrosian Camille L Chief Medical Officer | 216,910 | $0 | 275,243 (Direct) | View |